03 October 2017
By Dr Wendy Winnall - PCFA Research Team
Active surveillance is a monitoring strategy for patients with prostate cancer that aims to avoid or defer curative treatment. This approach helps to delay treatment side effects such as sexual problems, urinary and bowel incontinence. But active surveillance may bring a psychological cost. Men who use this strategy know that they have a cancer inside them that is not being treated. A new Australian study has compared the long-term psychological impact of active surveillance to immediate treatment for low-risk prostate cancer.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
